KYOWA KIRIN CO. LTD. |
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 2,656 JPY | +2.87% |
|
+3.41% | +12.05% |
| May. 07 | Kyowa Kirin's Profit Up 15% in Q1 | MT |
| May. 06 | Kyowa Kirin Buys Back Shares for 5.6 Billion Yen in April | MT |
ETFs positioned on Kyowa Kirin Co. Ltd.
| Name | Weight | AuM | 1st Jan change | Investor Rating |
|---|---|---|---|---|
| 2.22% | 19 M€ | +11.22% | ||
| 0.44% | 10 M€ | +15.87% | - | |
| 0.41% | 240 M€ | +17.47% | ||
| 0.39% | 28,258 M€ | +15.99% | - | |
| 0.36% | 64,792 M€ | +15.98% | ||
| 0.36% | 15,324 M€ | +15.05% | - | |
| 0.30% | 25 M€ | +16.23% | ||
| 0.27% | 4 M€ | +19.76% | ||
| 0.27% | 79 M€ | +18.46% | ||
| 0.26% | 70 M€ | +18.13% | ||
| 0.23% | 57 M€ | +19.30% | ||
| 0.20% | 0 M€ | -.--% | - | |
| 0.17% | 4,929 M€ | +18.61% | ||
| 0.17% | 9,760 M€ | +18.72% | ||
| 0.15% | 17 M€ | +14.54% | - | |
| 0.15% | 14 M€ | +5.66% | - | |
| 0.15% | 5 M€ | +10.09% | - | |
| 0.15% | 14 M€ | +19.96% | ||
| 0.13% | 20,360 M€ | +16.70% | - | |
| 0.13% | 140,441 M€ | +19.22% | ||
| 0.13% | 63,295 M€ | +18.52% | - | |
| 0.12% | 29 M€ | +8.37% | - | |
| 0.10% | 469 M€ | -2.05% | ||
| 0.10% | 3,859 M€ | +18.82% | - | |
| 0.09% | 4 M€ | -.--% | - | |
| 0.03% | 7 M€ | +0.11% | - | |
| 0.03% | 10 M€ | -3.35% | - | |
| 0.03% | 7 M€ | +5.36% | - | |
| 0.02% | 264 M€ | -.--% | - |
Kyowa Kirin Co., Ltd. specializes in the development, manufacturing and marketing of pharmaceutical and biochemical products. Net sales break down by source of revenue as follows:
- sales of pharmaceutical products (92.6%): prescription products for anemia, cancers, immune and nephrology diseases treatment;
- sales of licenses (7.4%).
At the end of 2021, the group had 3 production sites located in Japan (2) and China.
Net sales break down geographically as follows: Japan (60.9%), Asia (9%), Americas (16.3%) and Europe (13.8%).
Sector
Pharmaceuticals
Calendar
Related indices
Trading Rating
Investor Rating
ESG Refinitiv
A-
Sell
Buy
Mean consensus
OUTPERFORM
Number of Analysts
12
Last Close Price
2,656
JPY
Average target price
3,054
JPY
Spread / Average Target
+15.01%
EPS Revisions
| 1st Jan change | Capi. | |
|---|---|---|
| +12.05% | 9B | |
| +15.54% | 78.51B | |
| +58.17% | 4.96B | |
| -14.94% | 4.84B | |
| -.--% | 3.72B | |
| +21.94% | 2.48B | |
| -26.63% | 2.19B | |
| +16.75% | 2.12B | |
| -37.97% | 1.94B | |
| -0.50% | 1.64B |
- Stock Market
- Equities
- 4151 Stock
- Funds and ETFs Kyowa Kirin Co. Ltd.
